Search research articles
Contact Us
Filters
Showing results (81-90 of 115) with videos related to
Page
of 12
Sort By:
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
|
September 1, 2021
Levetiracetam, lamotrigine and carbamazepine: which monotherapy during pregnancy?
Luisa Mari, Fabio Placidi, Andrea Romigi, et al.
Epilepsia
|
October 13, 2009
Cerebrospinal fluid levels of the endocannabinoid anandamide are reduced in patients with untreated newly diagnosed temporal lobe epilepsy
Andrea Romigi, Monica Bari, Fabio Placidi, et al.
Sleep & Breathing = Schlaf & Atmung
|
February 23, 2021
Obstructive sleep apnea syndrome and Alzheimer's disease pathology: may continuous positive airway pressure treatment delay cognitive deterioration?
Claudio Liguori, Riccardo Cremascoli, Michelangelo Maestri, et al.
Brain, Behavior, & Immunity - Health
|
January 30, 2025
The potential role of interleukin-6 in the association between inflammation and cognitive performance in obstructive sleep apnea
Mariana Fernandes, Matteo Spanetta, Giorgio Vetrugno, et al.
Epilepsy & Behavior : E&B
|
January 15, 2013
Effects of zonisamide as add-on therapy on sleep-wake cycle in focal epilepsy: a polysomnographic study
Andrea Romigi, Francesca Izzi, Fabio Placidi, et al.
Sleep Medicine
|
September 18, 2022
Neuropsychiatric, neuropsychological, and neuroimaging features in isolated REM sleep behavior disorder: The importance of MCI
Mariacarolina Vacca, Francesca Assogna, Clelia Pellicano, et al.
CNS & Neurological Disorders Drug Targets
|
March 10, 2020
CSF Levels of the Endocannabinoid Anandamide are Reduced in Patients with Untreated Narcolepsy Type 1: A Pilot Study
Andrea Romigi, Monica Bari, Claudio Liguori, et al.
Parkinsonism & Related Disorders
|
April 2, 2019
Cerebral glucose metabolism in idiopathic REM sleep behavior disorder is different from tau-related and α-synuclein-related neurodegenerative disorders: A brain [18F]FDG PET study
Claudio Liguori, Roberta Ruffini, Enrica Olivola, et al.
Neurology
|
March 15, 2015
Nocturnal frontal lobe epilepsy with paroxysmal arousals due to CHRNA2 loss of function
Valerio Conti, Patrizia Aracri, Laura Chiti, et al.
Sleep
|
August 5, 2023
Cerebrospinal-fluid biomarkers for predicting phenoconversion in patients with isolated rapid-eye movement sleep behavior disorder
Mariana Fernandes, Silvia Maio, Paolo Eusebi, et al.
Page
of 12
Search research articles
Search
Showing results (81-90 of 115) with videos related to
Sort By:
Page
of 12
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
|
September 1, 2021
Levetiracetam, lamotrigine and carbamazepine: which monotherapy during pregnancy?
Luisa Mari, Fabio Placidi, Andrea Romigi, et al.
Epilepsia
|
October 13, 2009
Cerebrospinal fluid levels of the endocannabinoid anandamide are reduced in patients with untreated newly diagnosed temporal lobe epilepsy
Andrea Romigi, Monica Bari, Fabio Placidi, et al.
Sleep & Breathing = Schlaf & Atmung
|
February 23, 2021
Obstructive sleep apnea syndrome and Alzheimer's disease pathology: may continuous positive airway pressure treatment delay cognitive deterioration?
Claudio Liguori, Riccardo Cremascoli, Michelangelo Maestri, et al.
Brain, Behavior, & Immunity - Health
|
January 30, 2025
The potential role of interleukin-6 in the association between inflammation and cognitive performance in obstructive sleep apnea
Mariana Fernandes, Matteo Spanetta, Giorgio Vetrugno, et al.
Epilepsy & Behavior : E&B
|
January 15, 2013
Effects of zonisamide as add-on therapy on sleep-wake cycle in focal epilepsy: a polysomnographic study
Andrea Romigi, Francesca Izzi, Fabio Placidi, et al.
Sleep Medicine
|
September 18, 2022
Neuropsychiatric, neuropsychological, and neuroimaging features in isolated REM sleep behavior disorder: The importance of MCI
Mariacarolina Vacca, Francesca Assogna, Clelia Pellicano, et al.
CNS & Neurological Disorders Drug Targets
|
March 10, 2020
CSF Levels of the Endocannabinoid Anandamide are Reduced in Patients with Untreated Narcolepsy Type 1: A Pilot Study
Andrea Romigi, Monica Bari, Claudio Liguori, et al.
Parkinsonism & Related Disorders
|
April 2, 2019
Cerebral glucose metabolism in idiopathic REM sleep behavior disorder is different from tau-related and α-synuclein-related neurodegenerative disorders: A brain [18F]FDG PET study
Claudio Liguori, Roberta Ruffini, Enrica Olivola, et al.
Neurology
|
March 15, 2015
Nocturnal frontal lobe epilepsy with paroxysmal arousals due to CHRNA2 loss of function
Valerio Conti, Patrizia Aracri, Laura Chiti, et al.
Sleep
|
August 5, 2023
Cerebrospinal-fluid biomarkers for predicting phenoconversion in patients with isolated rapid-eye movement sleep behavior disorder
Mariana Fernandes, Silvia Maio, Paolo Eusebi, et al.
Page
of 12